Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 518

1.

Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.

Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG.

AIDS. 2004 Apr 30;18(7):981-9.

PMID:
15096800
[PubMed - indexed for MEDLINE]
2.

Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.

Kaplan SS, Ferrari G, Wrin T, Hellmann NS, Tomaras GD, Gryszowka VE, Fiscus SA, Weinhold KJ, Hicks CB.

AIDS Res Hum Retroviruses. 2005 Jan;21(1):13-6.

PMID:
15665640
[PubMed - indexed for MEDLINE]
3.

Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.

Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B.

AIDS. 1999 Dec 3;13(17):2365-76.

PMID:
10597778
[PubMed - indexed for MEDLINE]
4.

Prevalence and predictive value of intermittent viremia with combination hiv therapy.

Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK.

JAMA. 2001 Jul 11;286(2):171-9.

PMID:
11448280
[PubMed - indexed for MEDLINE]
5.

Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Price DA, Scullard G, Oxenius A, Braganza R, Beddows SA, Kazmi S, Clarke JR, Johnson GE, Weber JN, Phillips RE.

J Virol. 2003 May;77(10):6041-9.

PMID:
12719595
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.

Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.

Antivir Ther. 2007;12(6):971-5.

PMID:
17926652
[PubMed - indexed for MEDLINE]
7.

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.

Oxenius A, Price DA, Günthard HF, Dawson SJ, Fagard C, Perrin L, Fischer M, Weber R, Plana M, García F, Hirschel B, McLean A, Phillips RE.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13747-52. Epub 2002 Oct 7.

PMID:
12370434
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.

Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.

PMID:
19055701
[PubMed - indexed for MEDLINE]
9.

Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.

Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks SG.

J Virol. 2005 Nov;79(22):14169-78.

PMID:
16254352
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.

Ostrowski SR, Katzenstein TL, Thim PT, Pedersen BK, Gerstoft J, Ullum H.

J Infect Dis. 2005 Feb 1;191(3):348-57. Epub 2004 Dec 30.

PMID:
15633093
[PubMed - indexed for MEDLINE]
Free Article
11.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.

Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, Astriti M, Agher R, Calvez V, Autran B, Katlama C.

AIDS. 2005 Jan 3;19(1):25-33.

PMID:
15627030
[PubMed - indexed for MEDLINE]
12.

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.

Benito JM, López M, Lozano S, Martinez P, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2004 Feb;20(2):227-33.

PMID:
15018711
[PubMed - indexed for MEDLINE]
13.

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Deeks SG, Barbour JD, Grant RM, Martin JN.

AIDS. 2002 Jan 25;16(2):201-7.

PMID:
11807304
[PubMed - indexed for MEDLINE]
14.

Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.

Deeks SG, Martin JN, Sinclair E, Harris J, Neilands TB, Maecker HT, Hagos E, Wrin T, Petropoulos CJ, Bredt B, McCune JM.

J Infect Dis. 2004 Jan 15;189(2):312-21. Epub 2004 Jan 7.

PMID:
14722897
[PubMed - indexed for MEDLINE]
Free Article
15.

HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course.

Tenorio AR, Smith KY, Kuritzkes DR, Sha BE, Donoval B, Young R, Jennings C, Bremer J, Shott S, Landay A, Kessler HA.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):491-6.

PMID:
14657759
[PubMed - indexed for MEDLINE]
16.

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.

Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.

J Infect Dis. 1999 Aug;180(2):320-9.

PMID:
10395845
[PubMed - indexed for MEDLINE]
Free Article
17.

Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.

AIDS. 2000 May 5;14(7):761-70.

PMID:
10839583
[PubMed - indexed for MEDLINE]
18.

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.

Oxenius A, Price DA, Dawson SJ, Günthard HF, Fischer M, Perrin L, Ramirez E, Fagard C, Hirschel B, Scullard G, Weber JN, McLean AR, Phillips RE; Swiss HIV cohort study.

AIDS. 2002 Nov 22;16(17):2317-22.

PMID:
12441804
[PubMed - indexed for MEDLINE]
19.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG.

J Infect Dis. 2003 May 15;187(10):1534-43. Epub 2003 Apr 23.

PMID:
12721933
[PubMed - indexed for MEDLINE]
Free Article
20.

Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.

Mohey R, Jørgensen LB, Møller BK, Black FT, Kjems J, Obel N.

J Clin Virol. 2005 Dec;34(4):257-67. Epub 2005 Apr 18.

PMID:
16286049
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk